Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novartis files marketing applications for Prexige

Nov. 28, 2002

Two series of TNF-alpha production inhibitors identified at Sanofi-Synthelabo

Nov. 28, 2002

Celltech receives CDP-870 phase III milestone payment from Pharmacia

Nov. 28, 2002

Galapagos Genomics awarded grant for bone disease research

Nov. 27, 2002

Novel p38 inhibitors synthesized by Pfizer scientists

Nov. 21, 2002

Pharmacia updates Bextra label with new warnings

Nov. 21, 2002

Improved gastrointestinal safety profile reported for licofelone in osteoarthritis

Nov. 20, 2002

New inhibitors of VLA-4 receptors and cell adhesion presented by Aventis

Nov. 20, 2002

Novel PDE7 inhibitors and their use in arthritis, asthma, etc.

Nov. 18, 2002

New modulators of chemokine receptors under study at AstraZeneca

Nov. 13, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...